XPA-210: a new proliferation marker determines locally advanced prostate cancer and is a predictor of biochemical recurrence-Reference-Cited by-同舟云学术

XPA-210: a new proliferation marker determines locally advanced prostate cancer and is a predictor of biochemical recurrence

Published:2011-10-04 Issue:4 Volume:30 Page:547-552
ISSN:0724-4983
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

Aufderklamm Stefan,Hennenlotter Jörg,Todenhoefer Tilman,Gakis Georgios,Schilling David,Vogel Ulrich,Kuehs Ursula,Dlugosch Johannes,Knapp Judith,Merseburger Axel,Gerber Valentina,Ordelheide Anna,Hevler Joachim,Stenzl Arnulf,Schwentner Christian

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://link.springer.com/content/pdf/10.1007/s00345-011-0768-y.pdf

Reference22 articles.

1. O’Donnell H, Parker C (2008) What is low-risk prostate cancer and what is its natural history? World J Urol 26(5):415–422

2. Postma R et al (2005) Incidence and follow-up of patients with focal prostate carcinoma in 2 screening rounds after an interval of 4 years. Cancer 103(4):708–716

3. Zellweger T et al (2009) Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer. Int J Cancer 124(9):2116–2123

4. Nagao K et al (2011) Ki67 and BUBR1 may discriminate clinically insignificant prostate cancer in the PSA range <4 ng/ml. Jpn J Clin Oncol 41:555–564

5. Hannigan BM et al (1993) Thymidine kinases: the enzymes and their clinical usefulness. Cancer Biother 8(3):189–197

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A meta‑analysis of serological thymidine kinase 1 as a marker for colorectal benign and malignant tumor risk assessment;Molecular and Clinical Oncology;2020-02-25

2. Serum thymidine kinase 1 is associated with Gleason score of patients with prostate carcinoma;Oncology Letters;2018-08-21

3. Association of XPA polymorphism with breast cancer risk;Medicine;2018-06

4. Thymidine kinase 1 silencing retards proliferative activity of pancreatic cancer cell via E2F1-TK1-P21 axis;Cell Proliferation;2017-12-20

5. Muscle-invasive bladder cancer is characterized by overexpression of thymidine kinase 1;Urologic Oncology: Seminars and Original Investigations;2015-10